Unilateral and bilateral adrenalectomy for pheochromocytoma requires adjustment of urinary and plasma metanephrine reference ranges

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 3, 2013, Pages 1076-1083

  Osinga, Thamara E ^a   Van Den Eijnden, Maartje H A ^a   Kema, Ido P ^a   Kerstens, Michiel N ^a   Dullaart, Robin P F ^a   De Jong, Wilhelmina H A ^a   Sluiter, Wim J ^a   Links, Thera P ^a   Van Der Horst Schrivers, Anouk N A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; METADRENALIN; NORMETADRENALIN;

ADRENALECTOMY; ADULT; ANALYTIC METHOD; ARTICLE; BLOOD LEVEL; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PHEOCHROMOCYTOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; URINE LEVEL;

ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADULT; CHEMISTRY, CLINICAL; EPINEPHRINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METANEPHRINE; MIDDLE AGED; NORMETANEPHRINE; PHEOCHROMOCYTOMA; POSTOPERATIVE COMPLICATIONS; REFERENCE VALUES; RETROSPECTIVE STUDIES;

EID: 84874830910     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-3418     Document Type: Article

References (35)

1. McNicol AM, Young WF Jr, Kawashima A, Komminoth P, Tischer AS. Benign pheochromocytoma. In: DeLellis RA, Lloyed RV, Heitz PU, Eng C, eds. Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France: IARC Press; 2004:151-155.
2. Gimenez-Roqueplo AP, Dahia PL, Robledo M. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Horm Metab Res. 2012;44:328-333.
3. Lenders JW, Pacak K, Walther MM, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA. 2002;287:1427-1434. (Pubitemid 34250506)
4. Eisenhofer G, Keiser H, Friberg P, et al. Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J Clin Endocrinol Metab. 1998;83:2175-2185. (Pubitemid 28496356)
5. Lenders JW, Keiser HR, Goldstein DS, et al. Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Intern Med. 1995;123: 101-109.
6. Eisenhofer G, Kopin IJ, Goldstein DS. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev. 2004;56:331-349. (Pubitemid 39096594)
7. Wong DL. Epinephrine biosynthesis: hormonal and neural control during stress. Cell Mol Neurobiol. 2006;26:891-900.
8. Wurtman RJ, Axelrod J. Adrenaline synthesis: control by the pituitary gland and adrenal glucocorticoids. Science. 1965;150:1464-1465.
9. Robinson R. Tumours That Secrete Catecholamines: Their Detection and Clinical Chemistry. Chichester, UK: Wiley; 1980:1-11.
10. Plouin PF, Duclos JM, Soppelsa F, Boublil G, Chatellier G. Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. J Clin Endocrinol Metab. 2001;86:1480-1486. (Pubitemid 32374890)
11. Khan MB, Lee BR, Kamitani T. A simple and sensitive method for the demonstration of norepinephrine-storing adrenomedullary chromaffin cells. Histochem Cell Biol. 2012;138:155-165.
12. Amar L, Fassnacht M, Gimenez-Roqueplo AP, et al. Long-term postoperative follow-up in patients with apparently benign pheochromocytoma and paraganglioma. Horm Metab Res. 2012;44:385-389.
13. Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G, Plouin PF. Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab. 2005;90:2110-2116. (Pubitemid 40586247)
14. Goldstein RE, O'Neill JA Jr, Holcomb GW 3rd, et al. Clinical experience over 48 years with pheochromocytoma. Ann Surg. 1999;229:755-764.
15. Shen WT, Grogan R, Vriens M, Clark OH, Duh QY. One hundred two patients with pheochromocytoma treated at a single institution since the introduction of laparoscopic adrenalectomy. Arch Surg. 2010;145:893-897.
16. Neumann HP, Bausch B, McWhinney SR, et al; Freiburg-Warsaw-Columbus Pheochromocytoma Study Group. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002;346: 1459-1466. (Pubitemid 34755714)
17. Bryant J, Farmer J, Kessler LJ, Townsend RR, Nathanson KL. Pheochromocytoma: the expanding genetic differential diagnosis. J Natl Cancer Inst. 2003;95:1196-1204. (Pubitemid 37069549)
18. Erlic Z, Neumann HP. When should genetic testing be obtained in a patient with phaeochromocytoma or paraganglioma? Clin Endocrinol (Oxf). 2009;70:354-357.
19. Welander J, Soderkvist P, Gimm O. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer. 2011;18:R253-R276.
20. Willemsen JJ, Ross HA, Wolthers BG, Sweep CG, Kema IP. Evaluation of specific high-performance liquid-chromatographic determinations of urinary adrenaline and noradrenaline by comparison with isotope dilution mass spectrometry. Ann Clin Biochem. 2001;38:356-364. (Pubitemid 32626078)
21. de Jong WH, Eisenhofer G, Post WJ, Muskiet FA, de Vries EG, Kema IP. Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors. J Clin Endocrinol Metab. 2009;94:2841-2849.
22. de Jong WH, Graham KS, van der Molen JC, et al. Plasma free metanephrine measurement using automated online solid-phase extraction HPLC tandem mass spectrometry. Clin Chem. 2007;53: 1684-1693. (Pubitemid 47340066)
23. Muskiet FA, Thomasson CG, Gerding AM, Fremouw-Ottevangers DC, Nagel GT, Wolthers BG. Determination of catecholamines and their 3-O-methylated metabolites in urine by mass fragmentography with use of deuterated internal standards. Clin Chem. 1979;25:453-460. (Pubitemid 9142875)
24. Kema IP, Meiborg G, Nagel GT, Stob GJ, Muskiet FA. Isotope dilution ammonia chemical ionization mass fragmentographic analysis of urinary 3-O-methylated catecholamine metabolites. Rapid sample clean-up by derivatization and extraction of lyophilized samples. J Chromatogr. 1993;617:181-189. (Pubitemid 23248362)
25. Shah SD, Tse TF, Clutter WE, Cryer PE. The human sympathochromaffin system. Am J Physiol. 1984;247:380-384.
26. Eisenhofer G, Friberg P, Pacak K, et al. Plasma metadrenalines: do they provide useful information about sympatho-adrenal function and catecholamine metabolism? Clin Sci (Lond). 1995;88:533-542.
27. de Jong WH, de Vries EG, Kema IP. Current status and future developments of LC-MS/MS in clinical chemistry for quantification of biogenic amines. Clin Biochem. 2011;44:95-103.
28. Huang MH, Bahl JJ, Wu Y, et al. Neuroendocrine properties of intrinsic cardiac adrenergic cells in fetal rat heart. Am J Physiol Heart Circ Physiol. 2005;288:497-503.
29. Axelrod J. Purification and properties of phenylethanolamine-Nmethyl transferase. J Biol Chem. 1962;237:1657-1660.
30. Vargovic P, Ukropec J, Laukova M, et al. Adipocytes as anewsource of catecholamine production. FEBS Lett. 2011;585:2279-2284.
31. Tsujimoto G, Honda K, Hoffman BB, Hashimoto K. Desensitization of postjunctional α1-and α2-adrenergic receptor-mediated vasopressor responses in rat harboring pheochromocytoma. Circ Res. 1987;61:86-98. (Pubitemid 17123083)
32. Lenders JW, Willemsen JJ, Eisenhofer G, et al. Is supine rest necessary before blood sampling for plasma metanephrines? Clin Chem. 2007;53:352-354. (Pubitemid 46338282)
33. Eisenhofer G, Lenders JW, Timmers HJ, et al. Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin Chem. 2011;57:411-420.
34. Sanford TH, Storey BB, Linehan WM, Rogers CA, Pinto PA, Bratslavsky G. Outcomes and timing for intervention of partial adrenalectomy in patients with a solitary adrenal remnant and history of bilateral phaeochromocytomas. BJU Int. 2011;107:571-575.
35. Neumann HP, Reincke M, Bender BU, Elsner R, Janetschek G. Preserved adrenocortical function after laparoscopic bilateral adrenal sparing surgery for hereditary pheochromocytoma. J Clin Endocrinol Metab. 1999;84:2608-2610. (Pubitemid 30641980)